FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to expression systems of therapeutic proteins, and can be used in therapy to form sensory cells in an individual's inner ear. Replication-deficient adenoviral vector comprising a nucleic acid sequence encoding a protein homolog-1 protein of human atonal (Hath1), operably linked to a human glial fibrillary acidic protein (GFAP) gene promoter, is constructed.
EFFECT: invention enables effective stimulation of regeneration of sensory cells in the human inner ear.
15 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USE THEREOF | 2010 |
|
RU2604815C2 |
ADENOVIRUS CONTAINING ALBUMIN-BINDING SITE | 2015 |
|
RU2711371C2 |
ADENOVIRUS WITH DIRECTED GENE EXPRESSION AND USE THEREOF | 2003 |
|
RU2393221C2 |
SEQUENCE DISPOSED UPSTREAM FROM CARP GENE, VECTOR CONTAINING THE SAME AND USES THEREOF | 2001 |
|
RU2283865C2 |
RNAi AGENT OPTION | 2018 |
|
RU2789647C2 |
CHIMERIC ADENOVIRUSES APPLICABLE FOR TREATING MALIGNANT GROWTH | 2005 |
|
RU2448157C2 |
DEFECTIVE RECOMBINANT ADENOVIRAL VECTOR (VARIANTS) | 1994 |
|
RU2219241C2 |
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS | 2009 |
|
RU2520823C2 |
VECTORS FOR MULTIPLE GENE EXPRESSION | 2008 |
|
RU2462513C2 |
POLYVALENT VIRAL VECTORS AND SYSTEM FOR PRODUCING THEREOF | 2005 |
|
RU2416646C2 |
Authors
Dates
2019-11-22—Published
2015-10-09—Filed